Search

Per- and polyfluoroalkyl substances (PFAS) are compounds of emerging concern due to their persistence in the global water cycle and detection in drinking water sources. However, PFAS have been poorly studied in bottled water, especially in the United States. This study investigated the occurrence of PFAS and related factors in 101 uniquely labelled bottled water products for sale in the U.S. Products were screened for 32 target PFAS by solid phase extraction-liquid chromatography-tandem mass spectrometry (SPE-LC-MS/MS). Fifteen of 32 measured analytes were detected, consisting primarily of C3-C10 perfluorocarboxylic acids (PFCA) and C3-C6 and C8 perfluorosulfonic acids (PFSA). PFAS were detected above method detection limits in 39/101 tested products. The Σ32PFAS concentrations detected were 0.17–18.87 ng/L with a median of 0.98 ng/L; 97% of samples were below 5 ng/L. PFCA (83%) and short-chain perfluoroalkyl acids (PFAA) containing 5 or less CF2 groups (67%) were more prevalent on a mass basis than PFSA and longer-chain PFAA, respectively. Ultrashort-chain PFPrA, measured for the first time in bottled water, accounted for the greatest individual fraction of detected PFAS mass (42%) and was found almost exclusively in products labeled as Spring water. Purified water products contained significantly less PFAS than Spring water products, which was attributed to the use of reverse osmosis (RO) treatment in the majority of Purified waters (25/35) compared to Spring waters (1/45). RO-treated products contained significantly lower Σ32PFAS, long-chain, short-chain, and PFPrA concentrations than products without RO. Although no enforceable PFAS regulations exist for bottled water in the U.S., the finding that some products approach levels of concern justify a framework for monitoring PFAS in bottled water production.

Granular activated carbon (GAC) has proven to be a successful technology for per- and polyfluoroalkyl substances (PFAS) removal from contaminated drinking water supplies. Proper design of GAC treatment relies upon characterization of media service-life, which can change significantly depending on the PFAS contamination, treatment media, and water quality, and is often determined by fitting descriptive models to breakthrough curves. However, while common descriptive breakthrough models are favored for their ease-of-use, they have a significant shortcoming in that they are not able to properly fit PFAS desorption in competitive sorption scenarios. The present work adapts three common descriptive models to fit competitive PFAS breakthrough curves from a GAC pilot study. The adapted and original models were fit to the experimental breakthrough curves for 12 common PFAS and evaluated using adjusted R

The ability to perform laboratory testing near the patient and with smaller blood volumes would benefit patients and physicians alike. We describe our design of a miniaturized clinical laboratory system with three components: a hardware platform (ie, the miniLab) that performs preanalytical and analytical processing steps using miniaturized sample manipulation and detection modules, an assay-configurable cartridge that provides consumable materials and assay reagents, and a server that communicates bidirectionally with the miniLab to manage assay-specific protocols and analyze, store, and report results (i.e., the virtual analyzer). The miniLab can detect analytes in blood using multiple methods, including molecular diagnostics, immunoassays, clinical chemistry, and hematology. Analytical performance results show that our qualitative Zika virus assay has a limit of detection of 55 genomic copies/ml. For our anti-herpes simplex virus type 2 immunoglobulin G, lipid panel, and lymphocyte subset panel assays, the miniLab has low imprecision, and method comparison results agree well with those from the United States Food and Drug Administration-cleared devices. With its small footprint and versatility, the miniLab has the potential to provide testing of a range of analytes in decentralized locations.

An integrated system was implemented for water phytoremediation and biofuel production through sequential cultivation of filamentous algae followed by cultivation of lipid-producing microalgae Chlorella sorokiniana. Natural poly-culture of filamentous algae was grown in agricultural stormwater using the Algal Turf Scrubber®, harvested and subjected for lipid extraction and/or methane production using anaerobic digestion (AD). While filamentous algae lipid content was too low for feasible biodiesel production (

Scale-up of microalgal biofuel technology is challenged by availability of nitrogen and phosphorus fertilizers and the potential negative impact vast increases in chemical fertilizer demand would have on conventional agriculture. The current study investigated replacement of chemical fertilizers with nutrients sourced from primary and secondary wastewater effluents and anaerobic digestion centrate (ADC). Although primary wastewater effluent possessed a high optical density (OD) and bacterial contamination, it was a superior growth medium for microalgal cultivation than nutrient-scarce secondary effluent. Chlorella sorokiniana and Scenedesmus acutus f. alternans showed higher growth rates, productivities, and robustness than other species or poly-cultures of five species. While supplementing with 5–10% nutrient-rich ADC increased wastewater OD, it also enhanced microalgal growth rates from 0.2–0.3 d − 1 to 0.7–0.9 d − 1 and biomass productivity from 10 to 20 mg L − 1 d to 40–60 mg L − 1 d with greater improvements for secondary effluents. Supplementation with ADC also increased nutrient concentrations (N, P, Mn, B, Zn, Co by > 100% and S, Mg, Ca, Mo by 20–60%) and improved the nitrogen to phosphorus (N:P) ratio. Higher ADC dose of 20% inhibited microalgae growth potentially due to ammonia toxicity. Elevation of inoculum doses and light intensity increased final biomass density and productivity, with intensities − 2 s − 1 limiting algal growth rates. Inoculum doses of ≥ 2.5 × 10 5 cell mL − 1 were most favorable for cultivation of all tested microalgae and for FAME content and composition for a newly characterized strain of Chlorella sorokiniana . Overall, ADC represents an economical fertilizer substitute providing various nutrients needed for microalgal growth and enhancing biofuel sustainability.

Halogenated organic solvents such as chlorobenzenes (CBs) are frequent groundwater contaminants due to legacy spills. When contaminated anaerobic groundwater discharges into surface water through wetlands and other transition zones, aeration can occur from various physical and biological processes at shallow depths, resulting in oxic-anoxic interfaces (OAIs). This study investigated the potential for 1,2,4-trichlorobenzene (1,2,4-TCB) biodegradation at OAIs. A novel upflow column system was developed to create stable anaerobic and aerobic zones, simulating a natural groundwater OAI. Two columns containing (1) sand and (2) a mixture of wetland sediment and sand were operated continuously for 295 days with varied doses of 0.14–1.4 mM sodium lactate (NaLac) as a model electron donor. Both column matrices supported anaerobic reductive dechlorination and aerobic degradation of 1,2,4-TCB spatially separated between anaerobic and aerobic zones. Reductive dechlorination produced a mixture of di- and monochlorobenzene daughter products, with estimated zero-order dechlorination rates up to 31.3 μM/h. Aerobic CB degradation, limited by available dissolved oxygen, occurred for 1,2,4-TCB and all dechlorinated daughter products. Initial reductive dechlorination did not enhance the overall observed extent or rate of subsequent aerobic CB degradation. Increasing NaLac dose increased the extent of reductive dechlorination, but suppressed aerobic CB degradation at 1.4 mM NaLac due to increased oxygen demand. 16S-rRNA sequencing of biofilm microbial communities revealed strong stratification of functional anaerobic and aerobic organisms between redox zones including the sole putative reductive dechlorinator detected in the columns, Dehalobacter. The sediment mixture column supported enhanced reductive dechlorination compared to the sand column at all tested NaLac doses and growth of Dehalobacter populations up to 4.1 × 108 copies/g (51% relative abundance), highlighting the potential benefit of sediments in reductive dechlorination processes. Results from these model systems suggest both substantial anaerobic and aerobic CB degradation can co-occur along the OAI at contaminated sites where bioavailable electron donors and oxygen are both present.

This study investigated enhancing methane production from algal-bacteria biomass by adjusting the C/N ratio through co-digestion with a nitrogen-poor co-substrate - cellulose. A biomethane potential test was used to determine cumulative biogas and methane production for pure and co-digested substrates. Four kinetic models were evaluated for their accuracy describing experimental data. These models were used to estimate the total energy output and net energy ratio (NER) for a scaled AD system. Increasing the algal C/N ratio from 5.7 to 20-30 (optimal algae:cellulose feedstock ratios of 35%:65% and 20%:80%) improved the ultimate methane yield by >10% and the first ten days production by >100%. The modified Gompertz kinetic model demonstrated highest accuracy, predicting that co-digestion improved methane production by reducing the time-lag by ∼50% and increasing rate by ∼35%. The synergistic effects increase the AD system energy efficiency and NER by 30-45%, suggesting potential for substantial enhancements from co-digestion at scale.

Sustainable mass production of algal biofuels requires a reduction in nutrient demand and efficient conversion into fuels of all biomass including lipid-extracted algal residues (LEA). This study evaluated methane production, nutrient recovery and recycling from untreated and enzymatically pretreated Nannochloropsis LEA using semi-continuous anaerobic digestion (AD). Additionally, this process was compared to methane generation from whole Nannochloropsis alga (WA) and thermally pretreated WA. The methane production from untreated LEA and WA reached up to 0.22 L and 0.24 L per gram of biomass volatile solids (VS), respectively, corresponding to only 36–38% of the theoretical potential. Additionally, observed VS reduction was only 40–50% confirming biomass recalcitrance to biodegradation. While enzymatic treatment hydrolyzed up to 65% of the LEA polysaccharides, the methane production increased by only 15%. Alternatively, WA thermal pretreatment at 150–170 °C enhanced methane production up to 40%. Overall, an integrated process of lipid conversion into biodiesel coupled with LEA conversion into methane generates nearly 40% more energy compared to methane production from WA, and about 100% more energy than from biodiesel alone. Additionally, the AD effluent contained up to 60–70% of the LEA phosphorus content, 30–50% of the nitrogen, sulfur, calcium and boron, 20% of the iron and cobalt, and 10% of manganese, zinc and copper, which can partially replace chemical fertilizers during algal cultivation. Consequently, supplementation of Nannochloropsis cultures with 5% AD effluent was optimal for a high algal growth rate. Therefore, coupling biodiesel and methane production provides significant energy advantages along with sustainability and economic benefits from nutrient recycling.

The ability to perform laboratory testing near the patient and with smaller blood volumes would benefit patients and physicians alike. We describe our design of a miniaturized clinical laboratory system with three components: a hardware platform (ie, the miniLab) that performs preanalytical and analytical processing steps using miniaturized sample manipulation and detection modules, an assay‐configurable cartridge that provides consumable materials and assay reagents, and a server that communicates bidirectionally with the miniLab to manage assay‐specific protocols and analyze, store, and report results (i.e., the virtual analyzer). The miniLab can detect analytes in blood using multiple methods, including molecular diagnostics, immunoassays, clinical chemistry, and hematology. Analytical performance results show that our qualitative Zika virus assay has a limit of detection of 55 genomic copies/ml. For our anti‐herpes simplex virus type 2 immunoglobulin G, lipid panel, and lymphocyte subset panel assays, the miniLab has low imprecision, and method comparison results agree well with those from the United States Food and Drug Administration‐cleared devices. With its small footprint and versatility, the miniLab has the potential to provide testing of a range of analytes in decentralized locations.

Introduction: The challenge in precision medicine has been improving the understanding of cancer heterogeneity and clonal evolution, which has major implications in targeted therapy selection and disease monitoring. However, current bulk sequencing methods are unable to unambiguously identify rare pathogenic or drug-resistant cell populations and determine whether mutations co-occur within the same cell. Single-cell sequencing has the potential to provide unique insights on the cellular and genetic composition, drivers, and signatures of cancer at unparalleled sensitivity. Methods: Previously we have developed a high-throughput single-cell DNA analysis platform (TapestriTM) that leverages droplet microfluidics and a multiplex-PCR based targeted DNA sequencing approach, and demonstrated the generation of high-resolution maps of clonal architecture from acute myeloid leukemia (AML) tumors. Here we present an update to the Tapestri Platform which employs new biochemistry and features improved firmware, software, workflow, and data analysis solution resulting in higher throughput, better sensitivity, specificity and unprecedented flexibility. Results: From cell prep to sequencing-ready libraries, the workflow can be completed within 2 days, and new modifications have doubled the throughput to up to 20,000 genotyped cells per run from 10,000 shown previously. We have validated the performance of an AML (19 genes, 50 amplicons) and a CLL (chronic lymphocytic leukemia) (34 genes, 286 amplicons) panel. We also developed a robust web-based design portal for custom targets. The updated biochemistry enables easy addition of new gene and loci targets into existing panels for improved coverage and updated studies. Using longitudinal AML and CLL samples, we were able to detect rare subclones of Conclusion: We demonstrate that single-cell DNA sequencing can reveal the heterogeneity of blood cancers and map the clonal architecture and clonal evolution with higher sensitivity than bulk NGS methods. This is critical in patient stratification and drug selection over the entire course of treatment. Besides the catalog AML and CLL panels, the flexibility of system allows for analyzing SNV and indel mutations of any custom cancer DNA targets. Additionally, the system provides capabilities for quality control of gene edited cells, further advancing research into cancer therapies. Citation Format: Nianzhen Li, Daniel Mendoza, Adam Sciambi, Mani Manivannan, Jacob Ho, Kaustubh Gokhale, Jacqueline Marin, Kathryn Thompson, Jamie Yates, Vasu Sharma, Steven Chow, Sombeet Sahu, Shu Wang, Dennis Eastburn, Keith Jones. High-throughput single-cell targeted DNA sequencing using an updated TapestriTM Platform reveals rare clones and clonal evolution for multiple blood cancers [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 4696.

Background Thorough understanding of head and neck anatomy is useful and necessary for dermatologic surgery. Objective To highlight pertinent head and neck anatomic structures that are encountered during dermatologic surgery and correlate these with common surgical problems. Methods Important anatomic structures and regional cutaneous anatomy are discussed and illustrated. Results Several important anatomic structures exist within the head and neck that can influence surgical outcomes. Conclusion Anatomic knowledge is helpful to the dermatologic surgeon to optimize reconstructive outcomes.

Mohs surgery for a malignancy in the periungual and subungual location is advantageous because it is a tissue-sparing technique that preserves maximum function and normal appearance. Traditional surgical treatment for such tumors is wide local excision and closure; in some cases, amputation of the digit is considered. The amount of tissue removed with these standard surgical treatments may be quite debilitating for the patient. Often, Mohs surgery will preserve a significant amount of nail matrix so that an almost normal-appearing nail regrows.

To compare the efficacy of total skin electron beam therapy (TSEBT) with or without adjuvant topical nitrogen mustard (+/- HN2) with topical nitrogen mustard (HN2) alone as initial management of T2 and T3 mycosis fungoides (MF).A retrospective analysis of 148 patients presenting to Stanford from January, 1970 through January, 1995 within 4 months of pathologic diagnosis of MF. Fifty-five patients with T2 and 27 with T3 disease received TSEBT +/- HN2. Fifty-four patients with T2 and 12 with T3 disease received HN2 alone. Boosts with radiotherapy were usually administered to cutaneous tumors of patients with T3 disease.TSEBT +/- HN2 yielded significantly higher complete response (CR) rates than did HN2 alone in patients with T2 and T3 disease (76% vs 39%, p = 0.03 for T2, and 44% vs 8%, p0.05 for T3, respectively). In T2 disease, treatment with adjuvant HN2 was associated with a longer freedom from relapse following TSEBT when compared to observation following a CR to TSEBT (p = 0.068). However, no significant differences in survival were observed for different management programs for T2 or T3 disease. In T2 disease, both TSEBT and HN2 were as effective as salvage therapy as when utilized as initial therapy. However, salvage therapy in T3 disease was rarely effective. Limited tumor involvement in T3 disease did not correlate with improved survival compared to more generalized tumorous disease. MF contributed to 27% and 68% of deaths in patients with T2 and T3 disease, respectively.Because of high response rates, management of significantly symptomatic or extensive T2 MF should include TSEBT, and adjuvant HN2 should be administered after a CR to TSEBT. Patients with T2 disease who fail TSEBT or HN2 can be salvaged with the other modality. TSEBT is also an effective treatment for T3 disease. The small subset of patients with limited T3 disease may also be treated with HN2 and local radiotherapy to the tumors. Further investigations are necessary to improve the overall outcome for T3 mycosis fungoides.

The report on climate change and health commissioned by University College London and the Lancet concludes: “Climate change is the biggest global health threat of the 21st century.”1 In this report, the authors emphasise not only the immediacy and gravity of this threat but also the directness: while the poorest in the world will be …